Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly∗∗Access the “Journal Club” discussion of this paper at http:/www.elsevier.com/locate/ajmselect/

This publication has 28 references indexed in Scilit:

• IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.
  Journal of Clinical Investigation, 1998
• Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.
  Journal of Clinical Investigation, 1996
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
  Journal of the American College of Cardiology, 1996
• Do Post‐transcriptional Mechanisms Participate in Induction of C‐reactive Protein and Serum Amyloid A by IL‐6 and IL‐I?a
  Annals of the New York Academy of Sciences, 1995
• Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
  The Journal of Experimental Medicine, 1994
• C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo
  Arthritis & Rheumatism, 1992
• Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
  Science, 1992
• IFNβ2/BSF2/IL‐6 Is the Monocyte‐derived HSF That Regulates Receptor‐specific Acute Phase Gene Regulation in Hepatocytes^a
  Annals of the New York Academy of Sciences, 1989
• A case-cohort design for epidemiologic cohort studies and disease prevention trials
  Biometrika, 1986